News and Analysis

Neogene Therapeutics pulls in $110m Series A

Neogene Therapeutics Inc, a pre-clinical stage biotechnology company, has raised $110 million in Series A funding.

-

Neogene Therapeutics Inc, a pre-clinical stage biotechnology company, has raised $110 million in Series A funding. The investors included Jeito Capital, EcoR1 Capital, Syncona Vida Ventures, TPG and Two River.

Source: Press Release